A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for Migraine
114 locations incl. Birmingham
Sponsor: Kallyope Inc.
Sex: All·Age: 18 - 75
Code: NCT07645924·Phase 3·Recruiting·Listed Jun 12, 2026
Clinical research site in Ogden, Utah · 6028 S RIDGELINE DR STE 203, OGDEN, UT 84405-6911 · (801) 917-8410 · Website
Part of Advanced Research Institute
As of July 2026, 5 paid clinical trials are recruiting at Advanced Research Institute in Ogden, Utah. Active studies at this site cover conditions such as Acute Migraine, Atherosclerotic Cardiovascular Disease (ASCVD) and Celiac Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .